BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2232211)

  • 1. [Immunopathogenesis and clinical aspects of chronic GVHD after allogeneic bone marrow transplantation].
    Kubo K
    Nihon Rinsho; 1990 Sep; 48(9):2061-7. PubMed ID: 2232211
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
    Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation.
    Aranha FJ; Vigorito AC; De Sousa CA; Oliveira GB; Zulli R; Lorand-Metze I
    Haematologica; 2002 Feb; 87(2):219-20. PubMed ID: 11836174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
    Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease: clinical manifestation and therapy.
    Ratanatharathorn V; Ayash L; Lazarus HM; Fu J; Uberti JP
    Bone Marrow Transplant; 2001 Jul; 28(2):121-9. PubMed ID: 11509929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Graft vs host disease in a child undergoing allogeneic bone marrow transplantation].
    Nespoli L; Locatelli F
    Pediatr Med Chir; 1991; 13(1):17-23. PubMed ID: 2052451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypereosinophilia after allogeneic bone marrow transplantation. A possible role of IL-5 overproduction by donor T-cells chronic GVHD].
    Masumoto A; Sasao T; Yoshiba F; Kato S; Mori A; Okudaira H; Hotta T
    Rinsho Ketsueki; 1997 Mar; 38(3):234-6. PubMed ID: 9095665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
    Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary disease as the chief manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Ohtaka M; Suzuki A; Gotoh A; Nagasu M; Torii Y; Kimura Y; Ichinose Y; Toyama K; Serizawa H; Ebihara Y
    Rinsho Ketsueki; 1993 Feb; 34(2):153-8. PubMed ID: 8492413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
    Martin RW; Farmer ER; Altomonte VL; Vogelsang GB; Santos GW
    Arch Dermatol; 1995 Mar; 131(3):333-5. PubMed ID: 7887664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
    Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
    Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
    Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.